Search

everythinglearnresearchcommunity

for

Search:↓

People with lupus find fatigue and skin issues very bothersome, and even small improvements are meaningful.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

Ritlecitinib is safe and may effectively treat alopecia areata.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Inositol was not more effective than a placebo in treating trichotillomania.

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Both fluoxetine and clomipramine effectively treat dog lick dermatitis, but fluoxetine works faster with lower recurrence, while clomipramine has fewer side effects.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

The Scalp Coverage Scoring method reliably measures hair density from images.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Alopecia areata severity and symptoms vary by race and ethnicity.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Myhre syndrome symptoms worsen over time, with specific genetic variants affecting severity.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

AI is revolutionizing non-surgical cosmetic procedures by improving personalization, safety, and access.